Well....I don't know that we can call that successful. We declared victory after two patients and then ended the trial.
This one was a staggering failure because it gave us a false positive and plunged us into a trial failure from which we lost an entire drug, lots of money, and lots of credibility with how the interim and final results reporting was handled. Prurisol tanked the company harder than Mako.
The first half of this trial (interim report) was stupendously good. The second half was a disaster. This is probably why we can't partner it for decent money.